Oxford University COVID-19 vaccine will be ready on November 3

Oxford University COVID-19 vaccine will be ready on November 3

Last week, Argentina and Mexico announced they will produce the coronavirus vaccine jointly developed by Oxford University and pharmaceutical company AstraZeneca. The survey was conducted by WCIOM, a Russian state-owned pollster. Analysts say that if the vaccine is made by October and approved, it could give US President Donald Trump an additional advantage in the upcoming elections in November.

Chinese scientists are already leading work on at least eight other potential coronavirus vaccines that have entered different stages of clinical trials.

The vaccine developed by the German pharma company Curevac has also promised much hope after it successfully completed the phase 1 human trials. They said that next week more than 40,000 people in 45 medical centres will participate in a randomized, double-blind, placebo-controlled multicenter clinical study of the efficacy, immunogenicity and safety of the Sputnik V vaccine which will begin in Russian Federation simultaneously with the vaccination of volunteers from risk groups.

He said Russian Federation had received requests from various countries for more than a billion doses of the vaccine.

One of Sinopharm's inactivated COVID-19 vaccines on August 13 was revealed to have had a low rate of adverse reactions for patients in phase I and II clinical trials, while also demonstrating immunogenicity results.

Health officials and world leaders have criticised Russian Federation for releasing the vaccine in haste, by rushing through the first two phases of clinical trials.

These data informed the companies' decision to advance a 2-dose regimen of the 30µg dose level of BNT162b2, which encodes an optimized SARS-CoV-2 full-length spike glycoprotein (S), into a Phase 2/3 evaluation. Earlier, the World Health Organization had said that no corona virus vaccine would come before 2021.

China has been giving experimental coronavirus vaccines to groups facing high infection risks since July, a health official told state media.

Related Articles